Next Article in Journal
Synergy between Auranofin and Celecoxib against Colon Cancer In Vitro and In Vivo through a Novel Redox-Mediated Mechanism
Next Article in Special Issue
STAT3, a Master Regulator of Anti-Tumor Immune Response
Previous Article in Journal
The Use of Optimal Treatment for DLBCL Is Improving in All Age Groups and Is a Key Factor in Overall Survival, but Non-Clinical Factors Influence Treatment
Previous Article in Special Issue
Therapeutic Targeting of Stat3 Using Lipopolyplex Nanoparticle-Formulated siRNA in a Syngeneic Orthotopic Mouse Glioma Model
 
 
Article

Article Versions Notes

Cancers 2019, 11(7), 929; https://doi.org/10.3390/cancers11070929
Action Date Notes Link
article xml file uploaded 2 July 2019 17:51 CEST Original file -
article pdf uploaded. 2 July 2019 17:51 CEST Version of Record https://www.mdpi.com/2072-6694/11/7/929/pdf-vor
article supplementary file uploaded. 2 July 2019 17:51 CEST - https://www.mdpi.com/2072-6694/11/7/929#supplementary
article xml file uploaded 5 July 2019 05:47 CEST Update -
article xml uploaded. 5 July 2019 05:47 CEST Update https://www.mdpi.com/2072-6694/11/7/929/xml
article pdf uploaded. 5 July 2019 05:47 CEST Updated version of record https://www.mdpi.com/2072-6694/11/7/929/pdf
article supplementary file uploaded. 5 July 2019 05:47 CEST - https://www.mdpi.com/2072-6694/11/7/929#supplementary
article html file updated 5 July 2019 05:49 CEST Original file -
article html file updated 2 August 2019 12:56 CEST Update -
article html file updated 12 February 2020 23:48 CET Update -
article html file updated 20 July 2022 07:37 CEST Update https://www.mdpi.com/2072-6694/11/7/929/html
Back to TopTop